X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

PubWeight™: 6.82‹?› | Rank: Top 1%

🔗 View Article (PMID 9590285)

Published in Nat Genet on May 01, 1998

Authors

N S Heiss1, S W Knight, T J Vulliamy, S M Klauck, S Wiemann, P J Mason, A Poustka, I Dokal

Author Affiliations

1: Deutsches Krebsforschungszentrum, Department of Molecular Genome Analysis, Heidelberg, Germany.

Articles citing this

(truncated to the top 100)

RNomics: an experimental approach that identifies 201 candidates for novel, small, non-messenger RNAs in mouse. EMBO J (2001) 5.70

Telomere diseases. N Engl J Med (2009) 5.68

A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol (1999) 4.51

Ribosomopathies: human disorders of ribosome dysfunction. Blood (2010) 4.43

The telomere syndromes. Nat Rev Genet (2012) 4.01

Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 3.86

Danazol Treatment for Telomere Diseases. N Engl J Med (2016) 3.39

TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood (2008) 3.02

Nhp2p and Nop10p are essential for the function of H/ACA snoRNPs. EMBO J (1998) 2.91

The many facets of H/ACA ribonucleoproteins. Chromosoma (2005) 2.89

Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol (2000) 2.78

Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet (2007) 2.61

Syndromes of telomere shortening. Annu Rev Genomics Hum Genet (2009) 2.60

Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA. Mol Cell Biol (1999) 2.59

Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell (2014) 2.58

The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res (2007) 2.50

Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature (2014) 2.49

Nop58p is a common component of the box C+D snoRNPs that is required for snoRNA stability. RNA (1999) 2.48

Dyskeratosis congenita. Hematol Oncol Clin North Am (2009) 2.45

Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 2.44

Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A (2008) 2.37

Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature (2010) 2.36

Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res (2007) 2.34

In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol Cell Biol (2000) 2.27

Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet (2004) 2.23

Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood (2006) 2.22

Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev (2006) 2.20

Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One (2010) 2.19

A pseudouridine synthase required for the formation of two universally conserved pseudouridines in ribosomal RNA is essential for normal growth of Escherichia coli. RNA (1998) 2.12

Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood (2009) 2.12

Telomere maintenance and human bone marrow failure. Blood (2008) 2.09

Advances in the understanding of dyskeratosis congenita. Br J Haematol (2009) 2.05

Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins. EMBO J (2004) 2.04

Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A (2004) 2.01

TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99

The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood (2005) 1.95

Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood (2007) 1.93

Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet (2009) 1.86

RNA-guided RNA modification: functional organization of the archaeal H/ACA RNP. Genes Dev (2005) 1.86

X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet (1999) 1.80

Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica (2007) 1.80

Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology (2011) 1.77

Evolutionary appearance of genes encoding proteins associated with box H/ACA snoRNAs: cbf5p in Euglena gracilis, an early diverging eukaryote, and candidate Gar1p and Nop10p homologs in archaebacteria. Nucleic Acids Res (2000) 1.76

When ribosomes go bad: diseases of ribosome biogenesis. Mol Biosyst (2010) 1.76

Engineered telomere degradation models dyskeratosis congenita. Genes Dev (2008) 1.72

Translational control in cancer etiology. Cold Spring Harb Perspect Biol (2013) 1.71

The telomerase database. Nucleic Acids Res (2007) 1.69

Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood (2014) 1.64

Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta (2009) 1.62

Mutations in the SBDS gene in acquired aplastic anemia. Blood (2007) 1.62

Telomerase and idiopathic pulmonary fibrosis. Mutat Res (2011) 1.59

Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest (2013) 1.58

A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One (2009) 1.57

The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev (2007) 1.56

The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci U S A (2005) 1.56

Structure of H/ACA RNP protein Nhp2p reveals cis/trans isomerization of a conserved proline at the RNA and Nop10 binding interface. J Mol Biol (2011) 1.53

minifly, a Drosophila gene required for ribosome biogenesis. J Cell Biol (1999) 1.52

BMS1 is mutated in aplasia cutis congenita. PLoS Genet (2013) 1.50

The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50

Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita. Mol Cell Biol (2008) 1.46

Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet (2015) 1.46

Telomeres and disease. EMBO J (2009) 1.41

Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome. Hum Mol Genet (2010) 1.40

The cancerous translation apparatus. Curr Opin Genet Dev (2011) 1.38

Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Blood (2005) 1.37

A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci U S A (2008) 1.37

Accumulation of H/ACA snoRNPs depends on the integrity of the conserved central domain of the RNA-binding protein Nhp2p. Nucleic Acids Res (2001) 1.37

It all comes together at the ends: telomerase structure, function, and biogenesis. Mutat Res (2011) 1.36

Dyskeratosis congenita. FEBS Lett (2010) 1.36

Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res (2011) 1.35

Bioinformatic analysis of the nucleolus. Biochem J (2003) 1.30

Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest (2008) 1.29

Stable expression in yeast of the mature form of human telomerase RNA depends on its association with the box H/ACA small nucleolar RNP proteins Cbf5p, Nhp2p and Nop10p. Nucleic Acids Res (2001) 1.29

Conserved composition of mammalian box H/ACA and box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140. Mol Biol Cell (2000) 1.29

Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene. Hum Mutat (2013) 1.27

The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes. Nat Rev Cancer (2012) 1.27

Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Blood (2007) 1.26

Cotranscriptional recruitment of the pseudouridylsynthetase Cbf5p and of the RNA binding protein Naf1p during H/ACA snoRNP assembly. Mol Cell Biol (2005) 1.26

Structure and functional studies of the CS domain of the essential H/ACA ribonucleoparticle assembly protein SHQ1. J Biol Chem (2008) 1.26

Crystal structure determination and site-directed mutagenesis of the Pyrococcus abyssi aCBF5-aNOP10 complex reveal crucial roles of the C-terminal domains of both proteins in H/ACA sRNP activity. Nucleic Acids Res (2006) 1.24

Immunopurified small nucleolar ribonucleoprotein particles pseudouridylate rRNA independently of their association with phosphorylated Nopp140. Mol Cell Biol (2002) 1.23

Bone marrow failure and the telomeropathies. Blood (2014) 1.23

Telomeres and immunological diseases of aging. Gerontology (2009) 1.22

Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet (2004) 1.22

Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22

Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia (2011) 1.21

RNA pseudouridylation: new insights into an old modification. Trends Biochem Sci (2013) 1.20

DNA helicase and helicase-nuclease enzymes with a conserved iron-sulfur cluster. Nucleic Acids Res (2012) 1.20

Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts. Aging Cell (2007) 1.20

Cloning and characterization of a mammalian pseudouridine synthase. RNA (1999) 1.18

Integrative genomic analysis of human ribosomal DNA. Nucleic Acids Res (2011) 1.18

The primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway. Hum Mol Genet (2008) 1.18

Structure of a functional ribonucleoprotein pseudouridine synthase bound to a substrate RNA. Nat Struct Mol Biol (2009) 1.17

Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations. PLoS One (2011) 1.16

The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein. Mol Biol Cell (2002) 1.14

Mitochondria: impaired mitochondrial translation in human disease. Int J Biochem Cell Biol (2014) 1.13

Function of Apollo (SNM1B) at telomere highlighted by a splice variant identified in a patient with Hoyeraal-Hreidarsson syndrome. Proc Natl Acad Sci U S A (2010) 1.12

Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord (2011) 1.12

Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita. J Med Genet (2011) 1.11

Not all pseudouridine synthases are potently inhibited by RNA containing 5-fluorouridine. RNA (2004) 1.10

Articles by these authors

Lambda replacement vectors carrying polylinker sequences. J Mol Biol (1983) 32.76

A physical map of the human genome. Nature (2001) 12.39

The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature (2001) 7.95

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature (1990) 5.13

Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep (2000) 5.06

Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nat Genet (1996) 4.36

Cloning of the T gene required in mesoderm formation in the mouse. Nature (1990) 4.20

Selective isolation of cosmid clones by homologous recombination in Escherichia coli. Proc Natl Acad Sci U S A (1984) 4.11

Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. Genome Res (2001) 3.97

A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet (1996) 3.67

Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature (2000) 3.61

Complete DNA sequence of yeast chromosome XI. Nature (1994) 3.51

Analysis of cosmids using linearization by phage lambda terminase. Gene (1985) 2.98

Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis (2001) 2.69

Construction and use of human chromosome jumping libraries from NotI-digested DNA. Nature (1987) 2.58

Sequence interpretation. Functional annotation of mouse genome sequences. Science (2001) 2.54

A link between RNA interference and nonsense-mediated decay in Caenorhabditis elegans. Science (2000) 2.52

Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol (1998) 2.43

Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech Dev (1999) 2.36

Primer design for large scale sequencing. Nucleic Acids Res (1998) 2.31

Clustering of multiallele DNA markers near the Huntington's disease gene. J Clin Invest (1989) 2.25

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res (2001) 2.25

Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet (2007) 2.23

DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet (1997) 2.18

Molecular approaches to mammalian genetics. Cold Spring Harb Symp Quant Biol (1986) 1.99

Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet (1992) 1.91

Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet (1997) 1.89

Processing and quality control of DNA array hybridization data. Bioinformatics (2000) 1.86

Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol (1999) 1.84

miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene (2010) 1.82

A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia (1995) 1.81

Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J (1994) 1.80

X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet (1999) 1.80

Mutations downstream of the polyadenylation site of a Xenopus beta-globin mRNA affect the position but not the efficiency of 3' processing. Cell (1986) 1.76

Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet (1990) 1.75

Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr (2000) 1.74

A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet (1992) 1.73

Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie (2007) 1.72

Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol (2001) 1.70

A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3"-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum Mol Genet (1999) 1.70

Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A (1999) 1.69

Identifying splits with clear separation: a new class discovery method for gene expression data. Bioinformatics (2001) 1.67

The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys. Rapid communication. J Neural Transm (Vienna) (1997) 1.65

MASA syndrome is due to mutations in the neural cell adhesion gene L1CAM. Nat Genet (1994) 1.62

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene (2012) 1.62

Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol (2000) 1.60

Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry (2006) 1.59

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene (2011) 1.57

A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine. J Hyg (Lond) (1966) 1.51

Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest (1992) 1.50

Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry (2003) 1.47

A yeast artificial chromosome telomere clone spanning a possible location of the Huntington disease gene. Am J Hum Genet (1990) 1.41

Physical maps of 4p16.3, the area expected to contain the Huntington disease mutation. Genomics (1990) 1.39

Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36

Transcripts, genes and bands in 315,000 base-pairs of Drosophila DNA. J Mol Biol (1983) 1.35

DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res (2000) 1.32

Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood (2000) 1.31

Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood (2000) 1.29

A strategy for the selection of transcribed sequences in the Xq28 region. Hum Mol Genet (1992) 1.28

Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther (1999) 1.28

The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol Cell Biol (1990) 1.27

Human histone gene organization: nonregular arrangement within a large cluster. Genomics (1997) 1.27

Construction of a NotI linking library and isolation of new markers close to the Huntington's disease gene. Nucleic Acids Res (1988) 1.24

Automated low-redundancy large-scale DNA sequencing by primer walking. Biotechniques (1993) 1.24

Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol Psychiatry (2006) 1.23

Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet (1997) 1.21

Being in the right location at the right time. Genome Biol (2001) 1.21

Genomic organization of the adrenoleukodystrophy gene. Genomics (1994) 1.19

Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. Blood (1997) 1.19

Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita. Hum Mol Genet (1999) 1.18

G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Genet (1993) 1.17

Polyadenylation of the Xenopus beta 1 globin mRNA at a downstream minor site in the absence of the major site and utilization of an AAUACA polyadenylation signal. EMBO J (1985) 1.16

A family of cosmid vectors with the multi-copy R6K replication origin. Gene (1987) 1.16

Alternative splicing in the fragile X gene FMR1. Hum Mol Genet (1993) 1.16

The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics (1995) 1.16

Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors. J Neuropathol Exp Neurol (2000) 1.15

Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase. A novel bifunctional enzyme in malaria parasites. Eur J Biochem (2001) 1.14

Evolutionary implications of a complex pattern of DNA sequence homology extending far upstream of the hsp70 genes at loci 87A7 and 87C1 in Drosophila melanogaster. J Mol Biol (1982) 1.13